ArticleScience progress

Long-term progression-free survival in a patient with extensive-stage small-cell lung cancer following second-line therapy with anlotinib and palliative chemoradiotherapy: A case report.

Ning Zan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.